Variable/obesity group | BMIa | WCa | WHR | |||
---|---|---|---|---|---|---|
Prevalence (%, n) | Risk of health condition (odds ratio–95% CI)b | Prevalence (%, n) | Risk of health condition (odds ratio–95% CI)b | Prevalence (%, n) | Risk of health condition (odds ratio–95% CI)b | |
Diabetes (FPG ≥ 7 mmol/L) | ||||||
Non-obese | 11.8 (205) | Reference group | 10.7 (106) | Reference group | 9.8 (86) | Reference group |
Obese | 23.5 (207) | 1.81 (1.44–2.27) | 19.5 (277) | 1.51 (1.17–1.95) | 19.3 (296) | 1.68 (1.28–2.21) |
Diabetes (HbA1C ≥ 6.5) | ||||||
Non-obese | 6.9 (121) | Reference group | 6.1 (61) | Reference group | 4.9 (43) | Reference group |
Obese | 17.4 (153) | 2.13 (1.63–2.78) | 13.6 (193) | 1.67 (1.22–2.29) | 13.7 (211) | 2.20 (1.54–3.14) |
Hypertension (Sys ≥ 140 and/or Dias ≥ 90) | ||||||
Non-obese | 28.4 (494) | Reference group | 23.9 (237) | Reference group | 22.2 (195) | Reference group |
Obese | 38.5 (338) | 1.39 (1.16–1.66) | 38.0 (541) | 1.72 (1.42–2.09) | 37.9 (582) | 1.63 (1.33–1.98) |
Total cholesterol (≥ 5.0) | ||||||
Non-obese | 49.2 (859) | Reference group | 45.0 (457) | Reference group | 45.9 (405) | Reference group |
Obese | 56.5 (498) | 1.27 (1.07–1.50) | 55.0 (785) | 1.29 (1.09–1.5) | 54.3 (835) | 1.245 (1.05–1.48) |
Low HDL (< 1 for males and < 1.3 for females) | ||||||
Non-obese | 33.9 (592) | Reference group | 31.2 (311) | Reference group | 30.0 (265) | Reference group |
Obese | 43.2 (380) | 1.449 (1.26–1.77) | 40.1 (572) | 1.47 (1.23–1.76) | 40.2 (618) | 1.63 (1.36–1.96) |
LDL (> 3.34) | ||||||
Non-obese | 43.6 (761) | Reference group | 41.4 (413) | Reference group | 39.4 (348) | Reference group |
Obese | 51.4 (453) | 1.33 (1.13–1.58) | 49.3 (704) | 1.30 (1.10–1.55) | 49.9 (767) | 1.34 (1.12–1.59) |
Triglycerides (≥ 1.7) | ||||||
Non-obese | 32.3 (565) | Reference group | 28.0 (279) | Reference group | 26.7 (236) | Reference group |
Obese | 45.6 (401) | 1.72 (1.45–2.05) | 42.2 (602) | 1.85 (1.54–2.22) | 41.9 (644) | 1.67 (1.38–2.02) |
Snoring | ||||||
Non-obese | 14.1 (227) | Reference group | 13.0 (120) | Reference group | 14.7 (123) | Reference group |
Obese | 32.0 (265) | 2.52 (2.05–3.11) | 23.9 (315) | 1.74 (1.37–2.21) | 22.1 (311) | 1.28 (1.01–1.63) |
Sleep apnea | ||||||
Non-obese | 1.8 (31) | Reference group | 2.5 (24) | Reference group | 1.5 (13) | Reference group |
Obese | 4.4 (38) | 2.28 (1.39–3.73) | 25 (35) | 0.90 (0.52–1.56) | 3.1 (46) | 2.02 (1.06–3.85) |